Product status
Research material — not equivalent to an approved prescription product. This listing does not represent an approved therapeutic indication.
GHRH-analog research
Tesamorelin
A research listing with a necessary prescription distinction.
Tesamorelin is a synthetic growth hormone-releasing hormone, or GHRH, analog designed to stimulate endogenous growth hormone secretion. It has been studied in relation to lipolysis, body composition, metabolic markers, visceral adipose tissue, and aging-related research questions.
Research use only · Not for human consumptionThis AURA research listing is not an approved prescription product and is not represented as equivalent.
Current price$50.00
In stock
10 mg
Quantity
Research material only. Not equivalent to an approved prescription product and not for human consumption.1
Research context
Clear information before ordering.
Research has examined tesamorelin in settings involving growth-hormone signaling, fat metabolism, visceral adipose tissue, and cardiovascular-risk markers. A specific prescription tesamorelin product is FDA-approved only for reducing excess abdominal fat in adults with HIV-associated lipodystrophy and is not indicated for weight-loss management. This AURA research material is not represented as equivalent to that prescription product and does not guarantee body-composition or metabolic outcomes.
Product format
Research reference material. Verify the final label, net quantity, and batch identity before accepting the material.
Documentation
Request batch-specific identity, purity, and testing documentation from support when available.
Storage
Follow only the verified label and batch documentation. Contact support if product-specific storage information is not supplied.
Product questions
About Tesamorelin
Straight answers, responsible limits, and a direct path to support.
No. This listing is educational and research-focused and does not present the material as an approved treatment.